Jo Junyoung, Lee Yoon Jae
Department of Korean Gynecology, Conmaul Hospital of Korean Medicine, Seoul, Republic of Korea.
Department of Korean Gynecology, Jaseng Hospital of Korean Medicine, Seoul, Republic of Korea.
Acupunct Med. 2017 Jun;35(3):162-170. doi: 10.1136/acupmed-2016-011163. Epub 2017 Jan 11.
The aim of this systematic review was to assess the evidence from randomised controlled trials (RCTs) on the efficacy, effectiveness and safety of acupuncture in women with polycystic ovarian syndrome (PCOS) undergoing in vitro fertilisation (IVF) or intracytoplasmic sperm injection (ICSI).
We searched a total of 15 databases through October 2015. The participants were women with PCOS (diagnosed using the Rotterdam criteria) undergoing IVF or ICSI. Eligible trials were those with intervention groups receiving manual acupuncture (MA) or electroacupuncture (EA), and control groups receiving sham acupuncture, no treatment or other treatments. Outcomes included the clinical pregnancy rate (CPR), live birth rate (LBR), ongoing pregnancy rate (OPR) and incidence of ovarian hyperstimulation syndrome (OHSS) and adverse events (AEs). For statistical pooling, the risk ratio (RR) and its 95% (confidence interval) CI was calculated using a random effects model.
Four RCTs including 430 participants were selected. All trials compared acupuncture (MA/EA) against no treatment. Acupuncture significantly increased the CPR (RR 1.33, 95% CI 1.03 to 1.71) and OPR (RR 2.03, 95% CI 1.08 to 3.81) and decreased the risk of OHSS (RR 0.63, 95% CI 0.42 to 0.94); however, there was no significant difference in the LBR (RR 1.61, 95% CI 0.73 to 3.58). None of the RCTs reported on AEs.
Acupuncture may increase the CPR and OPR and decrease the risk of OHSS in women with PCOS undergoing IVF or ICSI. Further studies are needed to confirm the efficacy and safety of acupuncture as an adjunct to assisted reproductive technology in this particular population.
本系统评价旨在评估随机对照试验(RCT)中有关针刺对接受体外受精(IVF)或卵胞浆内单精子注射(ICSI)的多囊卵巢综合征(PCOS)女性的疗效、有效性及安全性的证据。
截至2015年10月,我们共检索了15个数据库。研究对象为接受IVF或ICSI的PCOS女性(根据鹿特丹标准诊断)。符合条件的试验为干预组接受手针(MA)或电针(EA),对照组接受假针刺、不治疗或其他治疗的试验。结局指标包括临床妊娠率(CPR)、活产率(LBR)、持续妊娠率(OPR)以及卵巢过度刺激综合征(OHSS)的发生率和不良事件(AE)。为进行统计合并,采用随机效应模型计算风险比(RR)及其95%置信区间(CI)。
选取了4项RCT,共430名参与者。所有试验均将针刺(MA/EA)与不治疗进行比较。针刺显著提高了CPR(RR 1.33,95%CI 1.03至1.71)和OPR(RR 2.03,95%CI 1.08至3.81),并降低了OHSS的风险(RR 0.63,95%CI 0.42至0.94);然而,LBR无显著差异(RR 1.61,95%CI 0.73至3.58)。没有RCT报告AE情况。
针刺可能提高接受IVF或ICSI的PCOS女性的CPR和OPR,并降低OHSS的风险。需要进一步研究以证实针刺作为辅助生殖技术在这一特定人群中的疗效和安全性。